Specialty Care Medication Site of Care/Infusible Updated Drug List
Customize your policy alerts
Sign up for all mclaren health plan policy alerts
Know when mclaren health plan releases new policies or updates existing guidance.
Monitor payer policy activity
Defines McLaren Health Plan's Site of Care requirements for certain specialty injectable and infusible medications for Community and McLaren Health Advantage members, including reimbursement exclusions for hospital outpatient infusion centers and potential preauthorization requirements.
Effective August 1, 2024, McLaren Health Plan updated the list of injectable/infusible medication codes subject to Site of Care requirements.
Infusions for the listed medications are excluded from reimbursement when administered in a hospital outpatient infusion center; they must be administered in a non-facility setting (home or non-hospital affiliated infusion center).
Medications on the list may still require preauthorization regardless of site of care; refer to the Service Codes Requiring Preauthorization list on the MHP website.
Exceptions to the site-of-care requirement may be made when a physician submits an authorization request with supporting documentation indicating contraindications to home or non-hospital infusion.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.